Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT06291415Phase 1Withdrawn
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
Autoimmune DiseasesBlood Coagulation DisorderBlood Platelet Disorder+14 more
StudydirectorStart date: 2024-04-02
NCT04579679Phase 2Terminated
Open-Label Surufatinib in European Patients With NET
Neuroendocrine Tumour of the LungNeuroendocrine TumoursSmall Intestinal NET
StudydirectorStart date: 2021-08-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Autoimmune DiseasesImmune System DiseasesThrombocytopenia
Similarity Score5%

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Blood Coagulation DisordersPurpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score5%

lei zhang, MD

Chinese Academy of Medical Science and Blood Disease Hospital

Related
19 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPrimary Immune Thrombocytopenia
Similarity Score5%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score3%

Jeffrey McCullough, MD

University of Minnesota

Related
5 trials

Shared therapeutic areas:

ThrombocytopeniaBlood Coagulation Disorders
Similarity Score3%

Barbara Konkle, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

Blood Coagulation DisordersThrombocytopenia
Similarity Score3%

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score3%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score3%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score3%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06291415Phase 1StudyDirector

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Autoimmune DiseasesBlood Coagulation DisorderBlood Platelet Disorder+14 more
Withdrawn
NCT04579679Phase 2StudyDirector

Open-Label Surufatinib in European Patients With NET

Neuroendocrine Tumour of the LungNeuroendocrine TumoursSmall Intestinal NET
Terminated

All 2 trials loaded